Retour sur lavenir.net
   European Medical S 4.920 € (0,00 %)     AB INBEV 73.480 € (-1,29 %)     ARGENX SE 748.400 € (-0,03 %)     CAMPINE 215.000 € (-0,46 %)     MELEXIS 81.550 € (+2,77 %)     TINC 11.540 € (0,00 %)     SYENSQO 65.000 € (-0,31 %)     D'IETEREN GROUP 171.500 € (+2,51 %)     KBC 117.650 € (+0,73 %)     UCB 253.400 € (-0,63 %)     ELIA GROUP 137.400 € (+1,93 %)     TUBIZE-FIN 217.400 € (-0,09 %)     UMICORE 21.020 € (0,00 %)     AEDIFICA 70.500 € (+0,14 %)     BEKAERT 40.050 € (-0,12 %)     WDP 22.300 € (-0,62 %)     BPOST 1.556 € (-0,38 %)     AGEAS 69.200 € (+0,44 %)     SOLVAY 27.000 € (-0,22 %)     EVS 28.200 € (-0,18 %)     SIPEF 92.700 € (+0,32 %)     PROXIMUS 6.105 € (-0,49 %)     CMB.TECH 13.300 € (-3,62 %)     CENERGY 24.500 € (+0,74 %)     SOFINA 221.000 € (0,00 %)     MONTEA 67.300 € (0,00 %)     JENSEN-GROUP 81.200 € (+0,50 %)     COLRUYT 35.500 € (+0,57 %)     ACKERMANS V.HAAREN 288.000 € (+0,70 %)     LOTUS BAKERIES 11 340.000 € (+0,35 %)     CIE BOIS SAUVAGE 298.000 € (-0,33 %)     GBL 79.800 € (+0,13 %)     VASTNED 29.550 € (-0,51 %)     BARCO 8.455 € (-0,41 %)     KBC ANCORA 81.000 € (+0,87 %)     QRF 11.150 € (0,00 %)     CELYAD ONCOLOGY 0.226 € (-9,60 %)     GIMV 44.425 € (+0,51 %)     NYRSTAR 0.064 € (-1,54 %)     RECTICEL 10.780 € (-0,74 %)     ASCENCIO 52.400 € (+0,19 %)     CFE 12.750 € (-0,78 %)     KINEPOLIS GROUP 35.200 € (-0,56 %)     VIOHALCO 20.550 € (-1,44 %)     AGFA-GEVAERT 0.423 € (-2,53 %)     VGP 83.700 € (+0,84 %)     XIOR 26.550 € (+0,38 %)     FLUXYS BELGIUM D 19.650 € (-0,76 %)     DEME GROUP 178.600 € (-0,11 %)     SOLVAC NOM(RETAIL) 76.000 € (0,00 %)     NYXOAH 1.450 € (+1,26 %)     AZELIS GROUP 9.805 € (-1,26 %)     NEXTENSA 46.110 € (-0,45 %)     IBA 16.560 € (+1,72 %)     FAGRON 24.100 € (-0,21 %)     SHURGARD 25.300 € (+0,20 %)     COFINIMMO 82.600 € (+2,42 %)     ECONOCOM GROUP 1.490 € (-1,00 %)     TITAN S.A. 53.650 € (0,00 %)     ONTEX GROUP 2.500 € (+0,81 %)  
   LLAMA GROUP 0.441 € (-7,17 %)     LIGHTON 7.510 € (+6,98 %)     AYVENS 11.570 € (+0,61 %)     FDJ UNITED 21.610 € (-1,37 %)     PLANISWARE 17.620 € (-1,45 %)     VIRIDIEN 85.550 € (-1,27 %)     INNATE PHARMA 1.582 € (-4,70 %)     VEOLIA ENVIRON. 36.000 € (+1,04 %)     MICHELIN 33.800 € (+0,69 %)     BNP PARIBAS ACT.A 102.160 € (+0,69 %)     VALNEVA 2.195 € (-3,35 %)     ATOS GROUP 33.100 € (-0,60 %)     SAINT GOBAIN 80.340 € (+0,63 %)     SOCIETE GENERALE 76.580 € (+0,74 %)     WALLIX 22.950 € (-0,22 %)     VALEO 13.450 € (-0,07 %)     CAPGEMINI 87.320 € (-1,89 %)     BOUYGUES 49.920 € (+0,77 %)     THALES 220.100 € (-2,31 %)     PHARMING GROUP 1.141 € (-0,78 %)     PHILIPS KON 23.740 € (+0,42 %)     TOTALENERGIES 69.030 € (-0,69 %)     STELLANTIS NV 5.172 € (-0,17 %)     AIR LIQUIDE 169.520 € (-0,14 %)     STMICROELECTRONICS 65.950 € (+4,09 %)     OVH 15.080 € (-6,22 %)     COVIVIO 54.500 € (+1,30 %)     DRONE VOLT 0.386 € (0,00 %)     PROSUS 38.055 € (-0,95 %)     DBT 0.051 € (+20,19 %)     INVENTIVA 2.975 € (-4,34 %)     ABIVAX 77.450 € (-4,03 %)     EURAZEO 40.780 € (-0,15 %)     ASML HOLDING 1 623.800 € (+4,51 %)     EDP 4.384 € (0,00 %)     TF1 6.600 € (-0,75 %)     SCHNEIDER ELECTRIC 282.450 € (+0,70 %)     J.MARTINS,SGPS 17.500 € (0,00 %)     AIRBUS 194.700 € (-0,21 %)     2CRSI 28.040 € (+5,41 %)     GENFIT 9.610 € (-8,13 %)     FREELANCE.COM 2.750 € (+1,48 %)     UNIBAIL-RODAMCO-WE 102.900 € (+0,73 %)     REXEL 37.060 € (+0,57 %)     NN GROUP 77.120 € (+1,61 %)     X-FAB 9.045 € (+2,67 %)     IBERSOL,SGPS 9.850 € (-1,50 %)     OSE IMMUNO 3.216 € (+0,19 %)     SANOFI 72.700 € (-1,16 %)     DASSAULT SYSTEMES 17.190 € (-1,15 %)     ASM INTERNATIONAL 1 024.500 € (+5,71 %)     OCI 4.008 € (+6,65 %)     UNILEVER 52.790 € (+0,08 %)     ADYEN 823.700 € (-2,41 %)     ERAMET 47.420 € (-0,38 %)     BE SEMICONDUCTOR 308.600 € (+5,36 %)     RELX 27.100 € (-1,95 %)     ICADE 19.030 € (-0,05 %)     PERNOD RICARD 65.700 € (-0,82 %)     TRIGANO 139.400 € (+4,34 %)  
News Réglementées
25/06/2026 07:00

Swiss Prime Site to breathe new life into the Maag halls

Swiss Prime Site AG / Key word(s): Miscellaneous
Swiss Prime Site to breathe new life into the Maag halls

25.06.2026 / 07:00 CET/CEST


PRESS RELEASE

Zug, 25 June 2026

  • The Maag halls in Zurich are to be preserved and renovated extensively with the aim of leasing them to a cultural institution over the long term
  • The pending appeal related to the «Maaglive» project that was filed with the Swiss Federal Supreme Court will be withdrawn
  • A Letter of Intent has been signed with the University of Zurich about leasing the Maag halls as a possible new location for the Natural History Museum

 

Swiss Prime Site has decided that it will not pursue the «Maaglive» project in Zurich. Uncertainty about the timing and nature of the project due to ongoing objections means that it is not possible to move forward as planned with «Maaglive», which envisaged the development of a culture pavilion, the construction of a residential tower and a tree-lined public square for the neighborhood. Swiss Prime Site will therefore withdraw the appeal that is pending before the Swiss Federal Supreme Court.

By taking this step, Swiss Prime Site is creating the basis for a sustainable and broadly supported development of the Maag site as a cultural centre within the city’s industrial district. The Maag halls are to be renovated extensively to create cultural spaces that can be used all year round and are accessible to a wide public. Under the current plans, the Maag halls would contain exhibition and event spaces, which would be complemented by a publicly accessible atrium in the Lichtstrasse area.

Swiss Prime Site aims to submit a planning application by the end of 2027 and to begin the renovation work in mid-2029. At present, the firm expects that the cost of the investment will run to approximately CHF 60 million. The current lease agreement with Maag Music & Arts for the temporary use of the Maag halls was recently extended by mutual agreement until the end of May 2029. This will ensure the public-oriented use of the halls until the planned start of construction.

As regards the future use of the Maag halls, Swiss Prime Site signed a Letter of Intent with the University of Zurich yesterday concerning a long-term lease of the historic building as a possible new location for the Natural History Museum of the University of Zurich.

A feasibility study produced by Swiss Prime Site confirms that the existing buildings could, in principle, be used to house a museum and it forms the basis for the Letter of Intent that was signed. The Maag halls contain large and versatile spaces and thus offer attractive development potential for the University of Zurich, which is carefully reviewing the project.

Marcel Kucher, Chief Executive Officer of Swiss Prime Site: «The ongoing legal uncertainty has prevented us from making concrete plans for the further development of Maaglive. We have therefore decided to discontinue the project in order to renovate the existing Maag halls for use as a cultural venue. While I regret the fact that the planned construction of apartments cannot go ahead, I am very pleased that the site will be used for cultural purposes that will deliver benefits far beyond the Prime Tower area and the City of Zurich. We are thus underscoring our ambition to create attractive mixed-used and sustainable living spaces for people in Switzerland. By preserving the Maag halls, we are laying the foundations for a sustainable and broadly supported development of the Maag site. The renovation will provide wide public access to the Maag halls and will bring new life to this part of the city through the year-round, public-oriented use of these spaces.»

Michael Schaepman, President of the University of Zurich, highlighted the great potential of the Maag site: «Swiss Prime Site’s proposal to turn the Maag halls into a museum is more than just an interesting option. This would enable Zurich to create another museum with international appeal. The University of Zurich is therefore examining the project carefully and with great interest.»

If you have any questions, please contact:

Media Relations & Investor Relations, Patrick Friedli
Tel. +41 58 317 17 75, patrick.friedli@sps.swiss



End of Media Release
View original content: EQS News


Language:English
Company:Swiss Prime Site AG
Poststrasse 4a
6300 Zug
Switzerland
Phone:+41 (0)58 317 17 17
E-mail:info@sps.swiss
Internet:www.sps.swiss
ISIN:CH0008038389
Listed:SIX Swiss Exchange
EQS News ID:2353462

 
End of NewsEQS News Service

2353462  25.06.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière